New study pits Clot-Removal devices against drugs for dangerous lung clots
Disease control
Not yet recruiting
This phase 3 trial will test three ways to treat intermediate high-risk pulmonary embolism (a serious blood clot in the lungs). The study compares two catheter-based procedures (mechanical clot removal or low-dose clot-busting drug) with standard blood-thinning heparin. About 210…
Phase: PHASE3 • Sponsor: Jesper Kjaergaard • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC